MYC and breast cancer: We investigated c-MYC copy number alterations and protein expression in breast cancer following radiotherapy for Hodgkin lymphoma (‘radiogenic breast cancer (RAD)', n=18; Supplementary Table 4) and age-matched cases for which there was no evidence of radiation exposure aetiology (‘sporadic breast cancer (SPO)', n=33; Supplementary Table 5).